Cairo-based pharmaceutical giant EIPICO has announced a cash dividend of EGP 2 per share, set for distribution in two equal installments on April 30 and August 29, 2024. The company reported a 28% year-on-year jump in 2023 consolidated net profits to EGP 823.3 million, with revenues soaring to EGP 5.23 billion from EGP 3.95 billion in 2022. Non-consolidated profits also surged 24% to EGP 730.08 million, reflecting strong operational performance.